Cancer clinical trial team receives prestigious award for the 2nd year in a row

May 13, 2015

A 17-member team of clinical cancer researchers has won the “Investigational New Drug Program Team Award” from the NCIC Clinical Trials Group for their dedication to the success of two lung cancer clinical trials. The trials focus on Reolysin (an oncolytic virus) and Selumetinib (a new targeted small-molecule therapy). It is the second year in a row that a team from The Ottawa Hospital has received this honour. The award recognizes the contributions of a non-MD team of clinical research associates, nurses, pharmacists and others toward the number of patients enrolled in the studies, ethics compliance, timeliness of data entry, and overall team work. Both trials are led by Dr. Garth Nicholas.

Team members: Kendra Christink, Michelle McWilliam, Matt Fish, Lisa Turriff, Amy Henderson, Lisa MacMullin, Femina Kanji, Nancy Drummond-Ivars, Kathy Lebreux, Maria Lalonde, Lise Thaw, Ruth Simpson, Lena McAleer, Emma Webster and Sharon Kelly.

Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with its faculties of Medicine and Health Sciences. The Ottawa Hospital Research Institute includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease. Support our research. Give to the Tender Loving Research campaign.

For further information, please contact

Lois Ross
Senior Communications Specialist
Ottawa Hospital Research Institute
Office: 613-737-8899 x73687
Cell: 613-297-8315